Anticorps Recombinant de lapin anti-CD134/OX40
CD134/OX40 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
FC
Conjugaison
CoraLite®594 Fluorescent Dye
CloneNo.
241398G7
N° de cat : CL594-98181
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en cytométrie | PHA-treated human PBMCs |
Dilution recommandée
| Application | Dilution |
|---|---|
| This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
CL594-98181 cible CD134/OX40 dans les applications de FC et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | CD134/OX40 Protéine recombinante Eg1261 |
| Nom complet | tumor necrosis factor receptor superfamily, member 4 |
| Masse moléculaire calculée | 29 kDa |
| Numéro d’acquisition GenBank | NM_003327 |
| Symbole du gène | CD134 |
| Identification du gène (NCBI) | 7293 |
| Conjugaison | CoraLite®594 Fluorescent Dye |
| Excitation/Emission maxima wavelengths | 588 nm / 604 nm |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS with 0.09% sodium azide and 0.5% BSA |
| Conditions de stockage | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Informations générales
CD134, also known as OX40 and TNFRSF4, is a member of the TNFR-superfamily of receptors (PMID: 2828930; 9766631). It is a type I transmembrane protein predominantly expressed on activated T cells which include CD4 and CD8 T cells, Th2, Th1, and Th17 cells, as well as regulatory T cells (Tregs) (PMID: 20307208). CD134 is activated by its cognate ligand CD134L (OX40L) and functions as a T cell co-stimulatory molecule (PMID: 26215166). CD134-CD134L interactions have been proposed as a potential therapeutic target for treating autoimmune diseases, cancer and infectious disease (PMID: 26215166; 19426222).
Protocole
| Product Specific Protocols | |
|---|---|
| FC protocol for CL594 CD134/OX40 antibody CL594-98181 | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |

